94 related articles for article (PubMed ID: 8400116)
1. Lack of increase or reduction in circulating platelet factor 4 and heparin-releasable platelet factor 4 in symptomatic patients with asthma.
Luzzatto G; Cella G; Boschetto P; Fabbri L
J Lipid Mediat; 1993 Jun; 7(2):151-4. PubMed ID: 8400116
[TBL] [Abstract][Full Text] [Related]
2. Increased releasability of platelet products and reduced heparin-induced platelet factor 4 release from endothelial cells in bronchial asthma.
Yasuba H; Chihara J; Kino T; Satake N; Oshima S
J Lipid Mediat; 1991; 4(1):5-21. PubMed ID: 1832572
[TBL] [Abstract][Full Text] [Related]
3. Platelet factor 4 (PF4) and heparin released platelet factor 4 (HR-PF4) in diabetes mellitus. Effect of the duration of the disease.
Cella G; Scattolo N; Vio C; Stevanato F; Lavagnini T; Padovan D; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):646-54. PubMed ID: 2435630
[TBL] [Abstract][Full Text] [Related]
4. Intra-platelet platelet factor 4 (IP.PF4) and the heparin-mobilisable pool of PF4 in health and atherosclerosis.
O'Brien JR; Etherington MD; Pashley M
Thromb Haemost; 1984 Jul; 51(3):354-7. PubMed ID: 6495255
[TBL] [Abstract][Full Text] [Related]
5. Platelet factor 4 release induced by intravenous administration of heparin.
Cella G; Scattolo N; Cappellato MG; Girolami A; Strauss WE; Sasahara AA
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):165-74. PubMed ID: 2581862
[TBL] [Abstract][Full Text] [Related]
6. Platelet factor 4 (PF4) and heparin-released platelet factor 4 (HR-PF4) in patients with cardiovascular disorders.
Cella G; Colby SI; Taylor AD; McCracken L; Parisi AF; Sasahara AA
Thromb Res; 1983 Mar; 29(5):499-509. PubMed ID: 6222505
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.
Carrier M; Knoll GA; Kovacs MJ; Moore JC; Fergusson D; Rodger MA
Thromb Res; 2007; 120(2):215-20. PubMed ID: 17098277
[TBL] [Abstract][Full Text] [Related]
8. Short-term effect of exercise on platelet factor 4 in normal subjects and in patients with coronary artery disease.
Placanica G; Migliau G; Nasso G; Rosso R; Tallarico D; Migliau G
Cardiologia; 1999 Nov; 44(11):993-6. PubMed ID: 10686775
[TBL] [Abstract][Full Text] [Related]
9. The Release of Tissue Factor Pathway Inhibitor and Platelet Factor 4 After Heparin Injection in Patients with Thrombocytosis.
Cella G; Conard J; Manai S; Luzzatto G; Paolini R; Toffoli S; Boeri G; Vianello A; Girolami A; Samama MM; Strauss WE
Hematology; 1997; 2(3):235-41. PubMed ID: 27406868
[TBL] [Abstract][Full Text] [Related]
10. Heparin-releasable platelet factor 4 in patients with coronary artery disease.
Sadayasu T; Nakashima Y; Yashiro A; Kawashima T; Kuroiwa A
Clin Cardiol; 1991 Sep; 14(9):725-9. PubMed ID: 1835913
[TBL] [Abstract][Full Text] [Related]
11. Markers of platelet activation in plasma of patients suffering from persistent allergic rhinitis with or without asthma symptoms.
Kasperska-Zajac A; Rogala B
Clin Exp Allergy; 2005 Nov; 35(11):1462-5. PubMed ID: 16297143
[TBL] [Abstract][Full Text] [Related]
12. The effect of increasing heparin doses and of heparinoid on platelet factor 4 (PF4) release in normal subjects.
Randi ML; Fabris F; Casonato A; Scattolo N; Cella G; Girolami A
Haematologica; 1984; 69(2):141-7. PubMed ID: 6429001
[No Abstract] [Full Text] [Related]
13. Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization.
Foo SY; Everett BM; Yeh RW; Criss D; Laposata M; Van Cott EM; Jang IK
Am Heart J; 2006 Aug; 152(2):290.e1-7. PubMed ID: 16875910
[TBL] [Abstract][Full Text] [Related]
14. Increased circulating concentrations of the counteradhesive proteins SPARC and thrombospondin-1 in systemic sclerosis (scleroderma). Relationship to platelet and endothelial cell activation.
Macko RF; Gelber AC; Young BA; Lowitt MH; White B; Wigley FM; Goldblum SE
J Rheumatol; 2002 Dec; 29(12):2565-70. PubMed ID: 12465153
[TBL] [Abstract][Full Text] [Related]
15. [Clinical studies on plasma platelet factor 4 in patients with bronchial asthma. Changes in bronchial inhalation tests by allergen and acetylcholine].
Toga H; Ohya N; Kitagawa S; Yoshida A
Arerugi; 1984 Aug; 33(8):474-9. PubMed ID: 6517718
[No Abstract] [Full Text] [Related]
16. Patients with paroxysmal atrial fibrillation but not paroxysmal supraventricular tachycardia display evidence of platelet activation during arrhythmia.
Atalar E; Haznedaroglu IC; Acil T; Ozer N; Kilic H; Ovunc K; Aksoyek S; Nazli N; Kes S; Kabakçi G; Kirazli S; Ozmen F
Platelets; 2003; 14(7-8):407-11. PubMed ID: 14713509
[TBL] [Abstract][Full Text] [Related]
17. Platelet function in acute myocardial infarction patients compared with controls.
O'Brien JR; Etherington MD; Shuttleworth RD; Calwell WH
Thromb Haemost; 1980 Oct; 44(2):96-9. PubMed ID: 7455998
[TBL] [Abstract][Full Text] [Related]
18. Heparin-platelet factor 4 antibodies in patients presenting to the ED with thrombosis.
Francis JL; Drexler A; Duncan MK; Walker JM; Hursting MJ; Levine RL
Am J Emerg Med; 2007 Mar; 25(3):279-84. PubMed ID: 17349901
[TBL] [Abstract][Full Text] [Related]
19. Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings.
Greinacher A; Alban S; Omer-Adam MA; Weitschies W; Warkentin TE
Thromb Res; 2008; 122(2):211-20. PubMed ID: 18262226
[TBL] [Abstract][Full Text] [Related]
20. Clinical study of platelet function and coagulation/fibrinolysis with Duraflo II heparin coated cardiopulmonary bypass equipment.
Nakajima T; Osawa S; Ogawa M; Sasaki T; Izumoto H; Yagi Y; Kawazoe K
ASAIO J; 1996; 42(4):301-5. PubMed ID: 8828788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]